News
International General Insurance Holdings Ltd. ("IGI" or the "Company") (NASDAQ: IGIC) today announced that its Board of ...
International General Insurance Holdings (IGI) has posted a decline in first-quarter net income for 2025, citing higher ...
IGI saw opportunities in energy, ports and terminals and marine cargo but remains cautious in long-tail lines.
Leaders of the gene-editing field join forces to develop and administer the first on-demand CRISPR therapy for an infant with ...
International General Insurance’s (IGI) Q1 combined ratio (CoR) deteriorated 20.3 points to 94.4% as catastrophe losses ...
Most of these factors are outside of the control of IGI and are difficult to predict. Factors that may cause such differences include, but are not limited to: (1) changes in demand for IGI’s ...
Results from the dose-escalation portion of the Phase 1 clinical study of ISB 2001 in ... 2025 /PRNewswire/ -- IGI, a global, fully integrated clinical-stage biotechnology company focused on ...
Core operating income, a non-GAAP measure, was $19.5 million for the first quarter of 2025, compared to $40.0 million for the same period in 2024. The Company generated a core operating return on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results